The 8 analysts offering 12-month price forecasts for X4 Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 5.00 and a low estimate of 2.60. The median estimate represents a +234.04% increase from the last price of 0.90.
The current consensus among 8 polled investment analysts is to Buy stock in X4 Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.16
Reporting Date Mar 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.